Support Alert

Class 2 medicines recall: Xarelto 20 mg film-coated tablets (Rivaroxaban)

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for a single batch of Xarelto 20mg film-coated tablets (Rivaroxaban) (Strathclyde Pharmaceuticals Ltd). This is due to a report of rogue blister strips of 15 mg tablets within two packs of 20 mg tablets.

Further details of the affected batch and action to take are available on the MHRA website.